Cargando…

Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with (225)Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer

It has been proven and confirmed in numerous repeated tests, that the use of a combination of several therapeutic methods gives much better treatment results than in the case of separate therapies. Particularly promising is the combination of ionizing radiation and magnetic hyperthermia in one drug....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cędrowska, Edyta, Pruszyński, Marek, Gawęda, Weronika, Żuk, Michał, Krysiński, Paweł, Bruchertseifer, Frank, Morgenstern, Alfred, Karageorgou, Maria-Argyro, Bouziotis, Penelope, Bilewicz, Aleksander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179151/ https://www.ncbi.nlm.nih.gov/pubmed/32106568 http://dx.doi.org/10.3390/molecules25051025

Ejemplares similares

Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy
por: Gawęda, Weronika, et al.
Publicado: (2020)

Lanthanide-Doped SPIONs Bioconjugation with Trastuzumab for Potential Multimodal Anticancer Activity and Magnetic Hyperthermia
por: Gawęda, Weronika, et al.
Publicado: (2020)

Functionalized TiO(2) nanoparticles labelled with (225)Ac for targeted alpha radionuclide therapy
por: Cędrowska, Edyta, et al.
Publicado: (2018)

Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy
por: Żuk, Michał, et al.
Publicado: (2021)

Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy
por: Piotrowska, Agata, et al.
Publicado: (2013)

(198)Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular Carcinoma
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2023)

Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment
por: Żuk, Michał, et al.
Publicado: (2022)

Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles
por: Żelechowska-Matysiak, Kinga, et al.
Publicado: (2023)

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

Supply and Clinical Application of Actinium-225 and Bismuth-213
por: Morgenstern, Alfred, et al.
Publicado: (2020)

An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
por: Morgenstern, Alfred, et al.
Publicado: (2018)

Preclinical Evaluation of (225)Ac-Labeled Single-Domain Antibody for the Treatment of HER2(pos) Cancer
por: Rodak, Magdalena, et al.
Publicado: (2022)

Treatment of Prostate Cancer with CD46-targeted (225)Ac Alpha Particle Radioimmunotherapy
por: Bidkar, Anil P., et al.
Publicado: (2023)

Trastuzumab-Modified Gold Nanoparticles Labeled with (211)At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
por: Dziawer, Łucja, et al.
Publicado: (2019)

Alpha radioimmunotherapy using (225)Ac-proteus-DOTA for solid tumors - safety at curative doses
por: Cheal, Sarah M., et al.
Publicado: (2020)

Radium and Francium beam tests to produce 225Ac/ 213Bi generators at CERN-MEDICIS
por: Bruchertseifer, Frank, et al.
Publicado: (2015)

Nanoparticles in Targeted Alpha Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2020)

(99m)Tc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2022)

α-Zirconium(IV) Phosphate: Static Study of (225)Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using (nat)Eu as a Model System for (225)Ac
por: Ondrák, Lukáš, et al.
Publicado: (2023)

Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles
por: Pala, Katarzyna, et al.
Publicado: (2013)

Enhanced Efficacy of Radioimmunotherapy Combined with Systemic Chemotherapy and Local Hyperthermia in Xenograft Model
por: Kinuya, Seigo, et al.
Publicado: (2000)

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction
por: Ménager, Jérémie, et al.
Publicado: (2015)

The in vivo fate of (225)Ac daughter nuclides using polymersomes as a model carrier
por: Kruijff, R. M. de, et al.
Publicado: (2019)

Adsorption of (137)Cs on titanate nanostructures
por: Filipowicz, Barbara, et al.
Publicado: (2014)

Development of [(225)Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration
por: Hull, Ashleigh, et al.
Publicado: (2023)

Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment
por: Silva, André C, et al.
Publicado: (2011)

On the relaxation time of interacting superparamagnetic nanoparticles and implications for magnetic fluid hyperthermia
por: Kuncser, Andrei, et al.
Publicado: (2019)

Superparamagnetic Oxygen-Loaded Nanobubbles to Enhance Tumor Oxygenation During Hyperthermia
por: Zullino, Sara, et al.
Publicado: (2019)

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With (212)Pb-TCMC-Trastuzumab
por: Meredith, Ruby F., et al.
Publicado: (2018)

Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals
por: Tsukrov, Dina, et al.
Publicado: (2016)

(225)Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
por: Sathekge, Mike, et al.
Publicado: (2018)

FZD10‐targeted α‐radioimmunotherapy with (225)Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model
por: Sudo, Hitomi, et al.
Publicado: (2021)

A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225
por: Salvanou, Evangelia-Alexandra, et al.
Publicado: (2020)

Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter (213)Bi
por: Cytryniak, Adrianna, et al.
Publicado: (2022)

Dose escalation study of targeted alpha therapy with [(225)Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy
por: Królicki, Leszek, et al.
Publicado: (2021)

Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy
por: Nosanchuk, J. D., et al.
Publicado: (2018)

Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy
por: Jurek, Przemysław M, et al.
Publicado: (2017)

Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms
por: Ansari, Shaquib Rahman, et al.
Publicado: (2022)

Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia
por: Dias, Alexandre M. M., et al.
Publicado: (2022)

Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the (213)Bi-labeled monoclonal antibody MX35 in an ovarian cancer model
por: Gustafsson-Lutz, Anna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e6884soeai4g1a3qbj9ob5ltph